Learn More
Description
The TU169 monoclonal antibody specifically binds to the human Major Histocompatibility Complex (MHC) Class II HLA-DQ1 and DQ2 antigens and weakly to HLA-DQ3. HLA-DQ antigens exits as heterodimers comprised of polymorphic transmembrane HLA-DQ alpha and beta glycoproteins. HLA-DQ is expressed primarily on B cells, monocytes, macrophages, dendritic cells and activated T lymphocytes. HLA-DQ is involved in presenting peptidic antigens to CD4+ T lymphocytes. This antibody does not cross-react with HLA-DR2 and HLA-DR7. This antibody fixes complement.
Specifications
Specifications
| Antigen | HLA-DQ |
| Classification | Monoclonal |
| Clone | Tu169 |
| Concentration | 0.2mg/mL |
| Conjugate | Brilliant Ultraviolet 395 |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Gene Alias | MHC class II HLA-DQ, MHC HLA-DQ |
| Host Species | Mouse |
| Purification Method | Affinity Purified |
| Quantity | 50 μg |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.